Full View

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia… - Proceedings of the …, 2005 - National Acad Sciences
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …
被引用次数：1236 相关文章

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia… - Proceedings of the …, 2005 - pubmed.ncbi.nlm.nih.gov
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …
[PDF] microfluidicfoundry.com

[PDF][PDF] Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia, AJ Rennekamp… - PNAS, 2005 - microfluidicfoundry.com
Untitled Page 1 Page 2 Inhibitors of cathepsin L prevent severe acute respiratory syndrome
coronavirus entry Graham Simmons*†, Dhaval N. Gosalia‡, Andrew J. Rennekamp*, Jacqueline …

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia, AJ Rennekamp… - Proceedings of the …, 2005 - cir.nii.ac.jp
抄録< jats: p> Severe acute respiratory syndrome (SARS) is caused by an emergent
coronavirus (SARS-CoV), for which there is currently no effective treatment. SARS-CoV …

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia… - Proceedings of the …, 2005 - ui.adsabs.harvard.edu
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …

Inhibitors of Cathepsin L Prevent Severe Acute Respiratory Syndrome Coronavirus Entry

G Simmons, DN Gosalia, AJ Rennekamp… - Proceedings of the …, 2005 - JSTOR
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

G Simmons, DN Gosalia, AJ Rennekamp… - Proceedings of the …, 2005 - europepmc.org
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …
[PDF] basedamy.com

[PDF][PDF] Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia, AJ Rennekamp, JD Reeves… - PNAS, 2005 - basedamy.com
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Page 1
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Graham …
[HTML] nih.gov

[HTML][HTML] Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia, AJ Rennekamp… - Proceedings of the …, 2005 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome (SARS) is caused by an emergent coronavirus (SARS-
CoV), for which there is currently no effective treatment. SARS-CoV mediates receptor …
[PDF] upenn.edu

[PDF][PDF] Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

G Simmons, DN Gosalia, AJ Rennekamp, JD Reeves… - PNAS, 2005 - seas.upenn.edu
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Page 1
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry Graham …